CVS Caremark Settles Out Of FTC Suit Over Insulin Pricing
The Federal Trade Commission reached a settlement on Tuesday with CVS Caremark that includes a number of changes to its business practices, the second deal in a case accusing the country's...To view the full article, register now.
Already a subscriber? Click here to view full article